02749nam 2200673 a 450 991014129000332120230628105033.097866136403079781280663376128066337597835276512693527651268978352763290935276329059783527651252352765125X(CKB)2670000000169189(EBL)875950(OCoLC)784885298(SSID)ssj0000657939(PQKBManifestationID)12248855(PQKBTitleCode)TC0000657939(PQKBWorkID)10680886(PQKB)11101280(MiAaPQ)EBC875950(Au-PeEL)EBL875950(CaPaEBR)ebr10558796(CaONFJC)MIL364030(Perlego)1011701(EXLCZ)99267000000016918920120604d2012 uy 0engurcn|||||||||txtccrPharmaceutical biotechnology drug discovery and clinical applications /edited by Oliver Kayser and Heribert Warzecha2nd., completely rev. and greatly enl. ed.Weinheim Wiley-Blackwell20121 online resource (677 p.)Description based upon print version of record.9783527329946 3527329943 Includes bibliographical references and index.pt. 1. Concepts and methods for recombinant drug production -- pt. 2. Bringing the drug into action : from downstreaming to approval -- pt. 3. Vaccines -- pt. 4. Recent applications in pharmaceutical biotechnology.This second edition of a very successful book is thoroughly updated with existing chapters completely rewritten while the content has more than doubled from 16 to 36 chapters. As with the first edition, the focus is on industrial pharmaceutical research, written by a team of industry experts from around the world, while quality and safety management, drug approval and regulation, patenting issues, and biotechnology fundamentals are also covered. In addition, this new edition now not only includes biotech drug development but also the use of biopharmaceuticals in diagnostics and vaccinations. <Pharmaceutical biotechnologyPharmaceutical biotechnology.615.19615/.19Kayser Oliver891116Warzecha Heribert987913MiAaPQMiAaPQMiAaPQBOOK9910141290003321Pharmaceutical biotechnology2258846UNINA